Proceedings of the International scientific and practical conference ―Oxford 2026: Science and Education Today‖ (May 29-31, 2026) / Publisher website: www.naukainfo.com. - Oxford, United Kingdom, 2026. - 392 p.

351 поверхневого рідинного шару дихальних шляхів і зміни реологічних властивостей мокротиння. СПИСОК ВИКОРИСТАНИХДЖЕРЕЛ: 1. Binay Kumar Shah , Bivek Singh , Yukun Wang , Shuanshuan Xie and Changhui Wang. Mucus Hypersecretion in Chronic Obstructive PulmonaryDisease and Its Treatment. 2023. DOI: 10.1155/2023/8840594 2. Roe T., Talbot T., Terrington I. et al. Physiology and pathophysiology of mucus and mucolytic use in critically ill patients. Critical Care. 2025. Vol. 29. P. 68. DOI: 10.1186/s13054-025-05286-x. 3. Ying W., Jing X., Chen L. et al. Research Progress on the Mechanisms of High Mucus Secretion in the Airway: A Scoping Review. Int J Chronic Obstr Pulmon Dis. 2026. Vol. 21. P. 588363. 4. Kelly S. J., Martinsen P., Tatkov S. Rapid changes in mucociliary transport in the tracheal epithelium caused by unconditioned room air or nebulized hypertonic saline and mannitol are not determined by frequency of beating cilia. ICMx. 2021. Vol. 9. P.8 5. Bennett W. D., Henderson A. G., Ceppe A., Zeman K. L., Wu J., Gladman C., Fuller F., Gazda S., Button B., Boucher R. C., Donaldson S. H. Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis. ERJ Open Research. 2020. Vol. 6. P. 00269-2020. 6. V. Terlizzi, E. Masi, M. Francalanci, G. Taccetti, D. Innocenti. Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice. Journal of Cystic Fibrosis. 2021. DOI 10.1186/s13052-021-01117-1 7. Maiz Carro L., Martínez-García M. A. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review. Therapeutic Advances in Respiratory Disease. 2019. Vol. 13. P. 1-15.